| Clinical data | |
|---|---|
| Other names | EE3; 17α-Ethynylestriol; 17α-Ethynylestra-1,3,5(10)-triene-3,16α,17β-triol |
| Routes of administration | By mouth |
| Drug class | Estrogen |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C20H24O3 |
| Molar mass | 312.409 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ethinylestriol (EE3), or17α-ethynylestriol, also known as17α-ethynylestra-1,3,5(10)-triene-3,16α,17β-triol, is asyntheticestrogen which was never marketed.[1]Nilestriol, the3-cyclopentylether of ethinylestriol, is aprodrug of ethinylestriol, and is a morepotent estrogen in comparison,[1] but, in contrast to ethinylestriol, has been marketed.[2] Ethinylestriol has been found to reduce the risk of7,12-dimethylbenz(a)anthracene (DMBA)-inducedmammary cancer when given as aprophylactic inanimal models, while other estrogens likeethinylestradiol anddiethylstilbestrol were ineffective.[3]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |